Koers Rock Creek Pharmaceuticals Inc Nasdaq
Aandelen
US7720812046
Farmaceutische producten
Omzet 2014 | - | Omzet 2015 | - | Marktkapitalisatie | 8,21 mln. 7,68 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -38 mln. -35,57 mln. | Nettowinst (verlies) 2015 | -6 mln. -5,62 mln. | EV/omzet 2014 | - |
Nettoliquiditeiten 2014 | 45K 42,12K | Nettoschuld 2015 | 19,86 mln. 18,59 mln. | EV/omzet 2015 | - |
K/w-verhouding 2014 |
-0,87
x | K/w-verhouding 2015 |
-1,04
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Talhia Tuck
IRC | Investor Relations Contact | 46 | 18-04-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,00% | 704 mld. | |
+27,45% | 577 mld. | |
-7,75% | 348 mld. | |
+18,53% | 327 mld. | |
+4,95% | 288 mld. | |
+14,81% | 234 mld. | |
+4,93% | 198 mld. | |
-9,78% | 194 mld. | |
-4,89% | 147 mld. |